Insider sale notice: 23,887 shares sold

PRVA filing reports a proposed sale of company common shares under a Form 144.

Rhea-AI Filing Summary

PRVA filing reports a proposed sale of company common shares under a Form 144. The notice lists option-originated shares dated 02/26/2026 totaling 5,361 in four option blocks (1,893; 1,100; 1,668; 700). It records that David Mountcastle sold 23,887 shares on 12/12/2025 for $597,793.14.

Insights

Corporate Governance Analyst

Form 144 notifies the market of proposed and recent insider sales.

The notice lists planned sales tied to option grants dated 08/28/2018, 03/20/2019, 12/04/2019, and 09/08/2020, with share amounts 1,893, 1,100, 1,668, and 700 respectively, showing the issuer as the source.

It also discloses a completed disposition by David Mountcastle of 23,887 shares on 12/12/2025 for $597,793.14. Timing and broader ownership context are not provided in the excerpt.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PRVA's Form 144 disclose about recent insider sales?

The filing shows a sale by David Mountcastle of 23,887 shares on 12/12/2025 for $597,793.14. It also lists option-based shares available for sale dated 02/26/2026 in four blocks.

Which option grants are listed as securities to be sold in PRVA's filing?

The notice lists option-originated common shares with grant dates 08/28/2018, 03/20/2019, 12/04/2019, and 09/08/2020, with share amounts 1,893, 1,100, 1,668, and 700 respectively.

How much did David Mountcastle receive from his reported sale in the filing?

The excerpt records proceeds of $597,793.14 from the disposition of 23,887 shares on 12/12/2025. The filing ties the sale to that single transaction and provides the dollar amount shown.

Does the Form 144 snippet state who will receive proceeds from the listed option sales?

The excerpt labels the method as Issuer for the option-originated shares dated 02/26/2026. The filing does not provide additional allocation or use-of-proceeds detail in the provided text.

Are the option-originated shares in the filing already sold or only proposed to be sold?

The document lists those option-derived common shares under a Securities To Be Sold heading with a transaction date of 02/26/2026, indicating planned sales rather than completed dispositions in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/26/2026 - 04:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5361	134030.88	123001529	02/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2026	Option Granted - 08/28/2018	Issuer			1893	02/26/2026	Cash
Common	02/26/2026	Option Granted - 03/20/2019	Issuer			1100	02/26/2026	Cash
Common	02/26/2026	Option Granted - 12/04/2019	Issuer			1668	02/26/2026	Cash
Common	02/26/2026	Option Granted - 09/08/2020	Issuer			700	02/26/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	12/12/2025	23887	597793.14

144: Remarks and Signature

Remarks
Date of Notice	02/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)